Ayman Al-Shurbaji
Department of Medical Laboratory Sciences and Technology
Huddinge University Hospital
Stockholm
Sweden
Name/email consistency: high
- The pharmacokinetics of ketobemidone are not affected by CYP2D6 or CYP2C19 phenotype. Al-Shurbaji, A., Säwe, J. Eur. J. Clin. Pharmacol. (2002)
- The pharmacokinetics of ketobemidone in critically ill patients. Al-Shurbaji, A., Tokics, L. Br. J. Clin. Pharmacol (2002)